Market research

Veterinary Medicine

Explore licenses

From the research team

360iResearch introduction

Veterinary Medicine: Executive Summary

Veterinary medicine encompasses the prevention, diagnosis, treatment, and management of disease in companion animals, livestock, aquatic species, and wildlife. Its development is shaped by animal-health needs, food safety, zoonotic-disease prevention, antimicrobial stewardship, regulatory oversight, and advances in diagnostics, therapeutics, surgery, and preventive care. The field increasingly operates at the intersection of animal, human, and environmental health under a One Health framework.

Transformative Shifts Reshaping Veterinary Practice

Veterinary medicine is moving from episodic treatment toward prevention, surveillance, and longitudinal care. Vaccination, parasite control, herd-health programs, biosecurity, nutrition, genetic selection, and routine screening are becoming more central to clinical and production decisions. Companion-animal care is also expanding into chronic-disease management, advanced surgery, rehabilitation, behavioral health, and geriatric medicine.

Digital records, remote consultation, connected monitoring devices, laboratory automation, and teletriage are changing workflows while raising questions about clinical accountability, data governance, and access. At the same time, antimicrobial-resistance concerns are strengthening stewardship requirements, diagnostic-led prescribing, infection prevention, and traceability across veterinary and food-production systems.

Artificial Intelligence Strengthens Veterinary Decision Support

Artificial intelligence is being applied to image interpretation, pathology, laboratory workflows, clinical documentation, epidemiological surveillance, drug discovery, and operational scheduling. These tools can help clinicians identify patterns, prioritize cases, reduce administrative burden, and integrate information from imaging, laboratory results, medical histories, and wearable devices.

The strongest applications are decision-support tools that complement professional judgment rather than replace it. Reliable adoption depends on representative training data, transparent validation, interoperability with practice systems, cybersecurity, privacy safeguards, and clear accountability when recommendations affect animal welfare or public health. Bias, limited data for uncommon species, and uneven digital infrastructure remain material constraints.

Regional Insights Across Veterinary Medicine

North America is characterized by advanced companion-animal services, specialized livestock production, sophisticated diagnostics, and active regulatory oversight. Latin America combines substantial agricultural and animal-production needs with growing companion-animal care, while uneven access to veterinary professionals, medicines, and diagnostic infrastructure remains important. Europe emphasizes animal welfare, food safety, antimicrobial stewardship, traceability, and integrated public-health governance.

The Middle East is shaped by livestock health, food-security priorities, companion-animal services, and varying regulatory capacity across countries. Africa faces a high burden of livestock and zoonotic-disease challenges alongside workforce, surveillance, and supply-chain constraints, creating a strong role for mobile services, vaccination, and community-based delivery. Asia-Pacific includes highly diverse animal-production systems, rapidly developing urban pet care, expanding research capacity, and significant needs in disease surveillance, biosecurity, and affordable access.

Group Insights: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN economies require approaches that account for dense production networks, cross-border animal movement, tropical diseases, and varied regulatory systems. BRICS members span major livestock, companion-animal, pharmaceutical, and research environments, making collaboration on surveillance, diagnostics, vaccine access, and antimicrobial stewardship particularly relevant. The European Union provides a strong framework for harmonized animal-health rules, welfare standards, traceability, and food-chain controls.

G7 countries generally combine mature clinical infrastructure, advanced research, and stringent regulatory expectations, while facing workforce pressures and rising demand for complex companion-animal care. GCC countries place emphasis on food security, livestock health, import controls, and modern clinical services. NATO members benefit from opportunities to strengthen cross-border preparedness for zoonotic threats, biological risks, and supply-chain disruptions, while recognizing that veterinary regulation remains primarily national or regional.

Country Insights: Diverse Priorities Across Leading Markets

Australia combines extensive livestock-health requirements with strong biosecurity priorities and developed companion-animal services. Brazil’s large agricultural base places emphasis on herd health, export compliance, vaccination, and disease surveillance. Canada and the United States have broad specialist, diagnostic, research, and companion-animal capabilities, alongside workforce and access considerations. Mexico balances livestock productivity, zoonotic-disease control, food safety, and expanding urban pet care.

China is strengthening animal-disease surveillance, production biosecurity, and clinical capacity across a large and diverse system. India faces substantial needs in livestock productivity, veterinary access, vaccination, and zoonotic-disease prevention. Japan and South Korea combine advanced technology with aging populations, mature companion-animal care, and high expectations for quality and traceability.

France, Germany, Italy, and Spain emphasize welfare, food safety, antimicrobial stewardship, production health, and regulated professional practice. The United Kingdom continues to prioritize biosecurity, responsible medicine use, animal welfare, and diagnostic capacity. Russia’s veterinary priorities include livestock health, disease control, food-chain security, and domestic supply resilience, with implementation shaped by geography and infrastructure.

Strategic Priorities for Veterinary Industry Leaders

Leaders should build integrated prevention programs that connect vaccination, diagnostics, nutrition, biosecurity, welfare, and antimicrobial stewardship. They should also invest in workforce development, specialist training, rural and mobile delivery models, and partnerships that improve access without compromising clinical quality.

Digital initiatives should begin with clearly defined clinical or operational problems, validated datasets, interoperable systems, and measurable safety outcomes. Organizations should establish governance for AI, telemedicine, cybersecurity, consent, and data ownership before scaling deployment. Regional strategies should be adapted to species mix, regulatory requirements, disease ecology, purchasing power, and local workforce capacity. Finally, leaders should strengthen supply-chain resilience and One Health collaboration among veterinarians, physicians, public-health authorities, laboratories, producers, and environmental specialists.

Research Methodology for the Veterinary Medicine Assessment

This executive summary uses a structured qualitative assessment of veterinary medicine as a multidisciplinary field. The analysis organizes established sector dynamics around clinical practice, animal production, companion-animal care, diagnostics, therapeutics, prevention, regulation, public health, technology adoption, workforce conditions, and supply-chain resilience.

Regional, group, and country perspectives are synthesized comparatively across the geographies specified for this assessment. Interpretations are framed as evidence-based industry themes rather than numerical market claims. Particular attention is given to One Health priorities, antimicrobial resistance, animal welfare, biosecurity, digital transformation, and differences in infrastructure, regulation, disease burden, and access to care.

Conclusion: Veterinary Medicine Advances Through Integration

Veterinary medicine is becoming more preventive, data-enabled, specialized, and closely connected to public health and food-system resilience. Progress will depend not only on clinical innovation but also on responsible antimicrobial use, reliable diagnostics, effective surveillance, skilled professionals, equitable access, and robust regulatory coordination.

The most durable strategies will combine scientific rigor with practical delivery. Organizations that integrate prevention, digital tools, workforce development, welfare, biosecurity, and One Health partnerships will be better positioned to address changing disease patterns and rising expectations for animal care while maintaining trust, safety, and professional accountability.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Veterinary Medicine Market, by Product Type
    1. 7.1Introduction
    2. 7.2Pharmaceuticals
      1. 7.2.1Antibiotics
      2. 7.2.2Parasiticides
      3. 7.2.3Immunomodulators
      4. 7.2.4Antivirals
    3. 7.3Vaccines
      1. 7.3.1Inactivated
      2. 7.3.2Live Attenuated
      3. 7.3.3Recombinant
    4. 7.4Biologics
      1. 7.4.1Monoclonal
      2. 7.4.2Cytokines
      3. 7.4.3Growth Factors
  8. 8.Veterinary Medicine Market, by Animal Type
    1. 8.1Introduction
    2. 8.2Companion Animals
      1. 8.2.1Cats
      2. 8.2.2Dogs
      3. 8.2.3Horses
      4. 8.2.4Rabbits
    3. 8.3Production Animals
      1. 8.3.1Cattle
      2. 8.3.2Poultry
      3. 8.3.3Swine
      4. 8.3.4Sheep
  9. 9.Veterinary Medicine Market, by Product Form
    1. 9.1Introduction
    2. 9.2Tablets
    3. 9.3Capsules
    4. 9.4Powders
    5. 9.5Liquids
  10. 10.Veterinary Medicine Market, by Route Of Administration
    1. 10.1Introduction
    2. 10.2Inhalation
    3. 10.3Injectable
    4. 10.4Oral
    5. 10.5Topical
  11. 11.Veterinary Medicine Market, by Disease Treatment
    1. 11.1Introduction
    2. 11.2Infectious Diseases
      1. 11.2.1Bacterial Infections
      2. 11.2.2Viral Infections
      3. 11.2.3Fungal Infections
    3. 11.3Parasitic Diseases
    4. 11.4Metabolic Disorders
      1. 11.4.1Diabetes
      2. 11.4.2Obesity
      3. 11.4.3Nutritional Deficiencies
    5. 11.5Orthopedic Disorders
      1. 11.5.1Arthritis
      2. 11.5.2Fractures
      3. 11.5.3Joint Dysplasia
    6. 11.6Dermatological Conditions
      1. 11.6.1Allergies
      2. 11.6.2Skin Infections
    7. 11.7Gastrointestinal Disorders
    8. 11.8Cardiology
    9. 11.9Neurology
  12. 12.Veterinary Medicine Market, by End User
    1. 12.1Introduction
    2. 12.2Veterinary Hospitals
    3. 12.3Veterinary Clinics
    4. 12.4Research Institutes
    5. 12.5Pet Owners
    6. 12.6Government & NGOs
  13. 13.Veterinary Medicine Market, by Distribution Channel
    1. 13.1Introduction
    2. 13.2Online
    3. 13.3Offline
  14. 14.Veterinary Medicine Market, by Region
    1. 14.1Introduction
    2. 14.2Asia-Pacific
    3. 14.3North America
    4. 14.4Latin America
    5. 14.5Europe
    6. 14.6Middle East
    7. 14.7Africa
  15. 15.Veterinary Medicine Market, by Group
    1. 15.1Introduction
    2. 15.2ASEAN
    3. 15.3GCC
    4. 15.4European Union
    5. 15.5BRICS
    6. 15.6G7
    7. 15.7NATO
  16. 16.Veterinary Medicine Market, by Country
    1. 16.1Introduction
    2. 16.2United States
    3. 16.3Canada
    4. 16.4Mexico
    5. 16.5Brazil
    6. 16.6United Kingdom
    7. 16.7Germany
    8. 16.8France
    9. 16.9Russia
    10. 16.10Italy
    11. 16.11Spain
    12. 16.12China
    13. 16.13India
    14. 16.14Japan
    15. 16.15Australia
    16. 16.16South Korea
  17. 17.Competitive Landscape
    1. 17.1Market Share Analysis, 2025
    2. 17.2Market Concentration Analysis, 2025
      1. 17.2.1Concentration Ratio (CR)
      2. 17.2.2Herfindahl Hirschman Index (HHI)
    3. 17.3Recent Developments & Impact Analysis, 2025
    4. 17.4Product Portfolio Analysis, 2025
    5. 17.5Benchmarking Analysis, 2025
  18. 18.Company Profiles
    1. 18.1Archer-Daniels-Midland Company
    2. 18.2Biogenesis Bago SA
    3. 18.3Biopharm company
    4. 18.4Biowet Puławy sp. z o.o.
    5. 18.5Brovapharma
    6. 18.6C H Boehringer Sohn AG & Co KG
    7. 18.7Ceva Sante Animale
    8. 18.8Dechra Pharmaceuticals PLC
    9. 18.9Elanco Animal Health Incorporated
    10. 18.10Evonik Industries AG
    11. 18.11Hester Biosciences Limited
    12. 18.12Indian Immunologicals Ltd.
    13. 18.13Intracin Pharmaceutical Private Limited
    14. 18.14JoinHub Pharma
    15. 18.15Merck & Co Inc.
    16. 18.16Nam Pharma Sdn Bhd
    17. 18.17NAPHAVET Co., Ltd.
    18. 18.18Neogen Corporation
    19. 18.19Nutreco NV
    20. 18.20Phibro Animal Health Corporation
    21. 18.21Sykes Vet International Pty Ltd.
    22. 18.22TRAVETCO
    23. 18.23Vetoquinol SA
    24. 18.24Vetpharma Animal Health S.L.
    25. 18.25Vetsintez LLC
    26. 18.26Virbac SA
    27. 18.27Weefsel Pharma
    28. 18.28Zoetis Inc.
  19. 19.Key Experts

Loading the sample request form…